HOME >> MEDICINE >> NEWS
Drug reverses bone loss in men with prostate cancer during the first year of treatment

e and can recover bone density that already has been lost," Ryan said.

Researchers also found a positive effect of zoledronic acid on bone markers, measurements of bone loss that are found in blood and urine. This study supports current guidelines that recommend monitoring bone density of men on hormone therapy and initiating bisphosphonate treatment if the bone density falls.

Prostate cancer is the most common cancer in men and the second leading cause of cancer-related death in American men. Overall, 1 in 6 men will develop prostate cancer during his lifetime.


'"/>

Contact: Rachel MacKnight
macknigh@ohsu.edu
503 494-8231
Oregon Health & Science University
25-Feb-2006


Page: 1 2

Related medicine news :

1. Scripps research team reverses Friedreichs ataxia defect in cell culture
2. Exercise reverses unhealthy effects of inactivity
3. Dynamic duo: Combination therapy reverses type 1 diabetes
4. Repetition reverses med students stethoscope shortcomings
5. New drug reverses effects of sleep deprivation on brain
6. Heart valve ring reverses damage from congestive heart failure, easing symptoms
7. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
8. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
9. African-American men understimate risk of prostate cancer
10. Treatment for early prostate cancer associated with type of specialist seen
11. Nonhormonal drug reduces hot flashes in men treated for prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... ... distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in ... and patient safety. Only a few hospitals and facilities have earned this distinction. ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick Taché ... Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is a ... & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011. ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma ... drugs, biologics and consumer health products, today announced that it had joined the ... as a non-profit organization to unite pharmaceutical and healthcare companies that share a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Today’s patients are ... this in mind, SIGVARIS has created a new line of anti-embolism stockings to ... and provide the benefits of graduated compression when transitioning from recovery to early ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... -- Global Interventional Radiology Market: Scope and Methodology ... market analyzes the current and future prospects of ... summary, including a market snapshot that provides overall ... research is a combination of primary and secondary ... research efforts along with information collected from telephonic ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
Breaking Medicine Technology:
Cached News: